Clinical Trials Directory

Trials / Conditions / Purpura, Thrombocytopenic

Purpura, Thrombocytopenic

8 registered clinical trials studyying Purpura, Thrombocytopenic — 1 currently recruiting.

StatusTrialSponsorPhase
WithdrawnThe Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune
NCT06291415
HutchmedPhase 1
RecruitingSpanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry
NCT05914441
Fundación Española de Hematología y Hemoterapía—
CompletedASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505
University Hospital, ToulousePhase 2
UnknownAtorvastatin in Management of Newly Diagnosed ITP
NCT03692754
Shandong UniversityPhase 2 / Phase 3
UnknownIdiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220
University Hospital, Bordeaux—
UnknownIdentifying Characteristics of Bone Marrow Failure Syndromes
NCT00315419
Office of Rare Diseases (ORD)—
CompletedPhase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
NCT00010387
Johns Hopkins UniversityPhase 2
CompletedDrug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302
National Heart, Lung, and Blood Institute (NHLBI)—